Publication | Closed Access
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272
110
Citations
25
References
2007
Year
Oncogenic AgentMedicineCell BiologyCancer GeneticsSystems BiologyOncologyRadiation OncologyLung CancerTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1